HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome of White pump shunt surgery for neovascular glaucoma in Asians.

Abstract
We compared the effect of seton (White pump shunt) surgery (16 eyes) with that of trabeculectomy and 5-fluorouracil (31 eyes) in treating 38 Asian patients with medically uncontrollable neovascular glaucoma. We found the probability of long-term success (intraocular pressure < or = 26 > or = 5 mm Hg) of seton surgery (53.0% at 3 years) to be similar to that obtained following trabeculectomy with adjunctive 5-fluorouracil (45.4% at 3 years). However, 3 years postoperatively, the probability of the preservation of visual acuity was significantly greater following trabeculectomy than seton surgery (67.1% vs 23.1%; P < .05). In addition, the prevalence of postoperative complications was higher with the seton procedure (P < .001). The loss of endothelial cells 6 months postoperatively was more marked with seton surgery than with trabeculectomy, whether the shunt device touched the cornea (P < .000001) or not (P < .0005). In conclusion, White's pump shunt was effective in lowering the IOP of eyes with neovascular glaucoma. However, care must be taken to prevent postoperative complications, the incidence of which exceeded those observed following trabeculectomy with adjunctive 5-fluorouracil.
AuthorsE Chihara, H Kubota, T Takanashi, N Nao-i
JournalOphthalmic surgery (Ophthalmic Surg) Vol. 23 Issue 10 Pg. 666-71 (Oct 1992) ISSN: 0022-023X [Print] United States
PMID1306663 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fluorouracil
Topics
  • Adult
  • Aged
  • Cell Count
  • Drainage (instrumentation)
  • Endothelium, Corneal (pathology)
  • Female
  • Fluorouracil (administration & dosage)
  • Glaucoma, Neovascular (ethnology, surgery)
  • Humans
  • Intraocular Pressure
  • Japan (ethnology)
  • Male
  • Middle Aged
  • Postoperative Complications
  • Prostheses and Implants
  • Trabeculectomy
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: